(Q28374675)

English

Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

4

0 references

5

object named as

P Cumming

0 references

author name string

P Deep

1

0 references

A Dagher

2

0 references

A Sadikot

3

0 references

language of work or name

0 references

publication date

15 December 1999

0 references

0 references

34

0 references

4

0 references

313-8

0 references

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

[3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

On the mode of action of amantadine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Exacerbation of schizophrenia associated with amantadine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Regulation of DOPA decarboxylase activity in brain of living rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Use of Amantadine in Parkinson's Disease. Results of a Double-blind Trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Pharmacological pallidotomy with glutamate antagonists.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Brain kinetics of L-[?-11 C]DOPA in humans studied by positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Controlled trial of amantadine hydrochloride in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819991215%2934%3A4%3C313%3A%3AAID-SYN7%3E3.0.CO%3B2-1

21 January 2018

Identifiers

10.1002/(SICI)1098-2396(19991215)34:4<313::AID-SYN7>3.0.CO;2-1

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28374675&oldid=1634686164"